Drug Utilization Research / Trends and comparisons

(C-101) A time-trend analysis of psychotropic drug prescription patterns in a Peruvian inpatient population during the COVID-19 pandemic

(C-065) Age-specific Drug Utilization Patterns Among Pregnant Women in Taiwan: A Nationwide Cohort Study

(C-081) An Algorithm for Mapping the Treatment Sequences of Patients with COPD: Development and Application in a Canadian Cohort.

(C-079) Antibiotic Prescribing Trends by Provider Specialty and Drug Class Before and During the COVID-19 Pandemic (2013-2022)

(C-108) Antidepressant use in a nationally representative cohort of older adults: longitudinal use and polypharmacy

(B-116) Antipsychotic Use Before and After Foster Care Enrollment Among Youth in Medicaid

(C-071) Association Between Opioid Use Disorder (OUD) Treatment Modalities and Opioid-Related Hospitalizations Among Medicare Beneficiaries

(B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies

(C-073) Barriers and Facilitators to Deprescribing Opioids in High-Risk Older Adults: A comparison based on cirrhosis status

(C-085) Belatacept Use Among U.S. Kidney Transplant Recipients (2011-2020)

(A-143) Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

(B-118) Bibliometric Analysis of Global Research Trends and Themes in ADHD

(B-113) Changes in Initial Maintenance Inhaler Regimens for Canadian Patients with Chronic Obstructive Pulmonary Disease from 2018-2023: A Multi-Province Analysis

(C-066) Channeling Bias in First-Line Prescribing of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Individuals with Severe Mental Illness and Diabetes

(C-105) Characterizing Demographics and Comorbidities for New Initiator GLP-1 Patients, 2016 – 2023

(C-069) Comparison of Expenditure and Utilization of Top 25 High-Cost Drugs Across Canada and Comparable Countries

(C-089) Comparison of Opioid Prescribing Before and After Onset of the COVID-19 Pandemic in the USA (2018-2022)

(B-125) Contact with the Health Care System Among Older Adults with HER2-Positive Metastatic Breast Cancer

(B-137) Contemporary Trends in Oral Anticoagulant Use Among Patients with Atrial Fibrillation and Cancer in UK Primary Care

(C-067) COVID-19 Pandemic and Statin Adherence in Sweden: Insights from Cohort Analyses Before and During the Crisis

(B-134) DARWIN EU® - Paracetamol prescribing in Europe: a descriptive analysis of incidence and prevalence rates

(C-087) DARWIN EU® - Prescription pattern of STOPP section K criteria medication in elderly with and without recurrent falls

(C-086) Evaluating the Impact of GAAT Criteria on the Development of Antimicrobial Resistance in ICU Patients Receiving Parenteral Antimicrobial Therapy

(C-075) Evaluating treatment patterns in newly diagnosed Pulmonary Arterial Hypertension patients: First network study in PHederation, the Pulmonary Hypertension federated data network

(C-068) Expenditure and Utilization on GLP-1 Medications across High-Income Countries: A repeated cross-sectional analysis

(B-133) Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community: A Cross-National Comparison

(B-117) Initial opioid prescriptions for non-cancer patients in Yinzhou China: a retrospective, observational study based on regional medical data during 2011-2023

(B-130) Initiation of anticoagulants during the COVID-19 pandemic in Sweden: an interrupted time series analysis

(C-107) Investigating Treatment Pathways for Rheumatoid Arthritis in Adult Patients: Insights from Real-World Data

(B-128) Medical Cannabis Use in Association with Drugs Associated with Risks of Interaction with Cannabinoids: A Longitudinal Cohort Study

(C-080) Naloxone Prescribing Trends Among Regions and Providers of the United States: Analysis of Medicare Part D Prescriber Data 2013-2022

(B-120) Optic Neuritis and Corticosteroid Utilization among Patients with Multiple Sclerosis: An Electronic Medical Records Study

(B-126) Oral antibiotic use with focus on fluoroquinolones during 2010-2021 in four European countries: Finnish results of the HORIZON-EU project “Real4Reg”

(C-084) Oral Anticoagulant Use by Comorbidity in Long-term Care: A Population-based Cross-Sectional Study

(C-094) Osteoporosis Pharmacotherapy in people with and without Parkinson’s disease in Finland

(C-088) Patterns of Opioid Reinitiation: Insights from US National Data (2018-2022)

(B-124) Pharmacoepidemiological study about the usage of antidepressants in young adults in Greece

(C-100) Prescribing Patterns and Lipid Control Outcomes of PCSK9 Inhibitors in the Greater Bay Area of China

(B-127) Proton pump inhibitor use in infants younger than one year of age: Nationwide Cohort Study Based on the French EPI-MERES Register

(C-078) Psychotropic Medication Use among Youth with Schizophrenia in Medicaid Foster Care Program

(C-070) Racial and Ethnic Differences in Initiation and Continuation of Treatment Among Medicare Beneficiaries with Opioid Use Disorder from 2010-2019

(B-132) Raloxifene Use Over Time Among U.S. Medicare Beneficiaries

(B-122) Real-World Trends in Prenatal Antirheumatic Drug Utilization in Ontario, Canada: A Cross-Sectional Time Series Analysis

(B-119) Real-World Utilization Patterns and Adherence to Subcutaneous and Oral Semaglutide in Adults with Type 2 Diabetes Treated in UK Primary Care

(C-063) Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020

(B-114) Temporal Trends in Clinical Characteristics and Treatment Patterns of Patients with Both CKD and T2D Initiating a GLP-1 RA and SGLT2i: Findings From a Large Database in the United States, 2014-2023

(C-074) The temporal trends of Escherichia coli antimicrobial resistance and antibiotic utilization in Australian Long-Term Care Facilities

(C-095) Trajectories of Osteoporosis Pharmacotherapy among Older Treatment-Naïve Females

(C-103) Treatment of Type 2 Diabetes Among Medicare Beneficiaries With and Without Alzheimer’s Disease: A Retrospective Cohort Study

(C-093) Treatment patterns in pediatric type 1 diabetes mellitus patients in Taiwan

(C-072) Treatment Patterns of Immunoglobulin Replacement Therapy Among Patients with Multiple Myeloma in the United States: a Real-World Analysis

(C-099) Trends in Clinical Prescription Patterns and Selection of Anabolic drugs for postmenopausal women with osteoporosis in Taiwan

(C-090) Trends in insulin utilization and SARIMA forecasting: A time-series analysis in Greece (2016–2023) using IQVIA dataset

(B-135) Trends in Menopausal Hormone Therapy dispensing in Australia between 2014 and 2023

(C-092) Trends in opioid prescribing prior to opioid toxicity inpatient hospitalizations and ED visits in Canada, 2018-2022

(C-091) Trends in Outpatient Antibiotic Prescribing in the United States using Real World Data from 2020 to 2024

(B-112) Trends in Outpatient Influenza Antiviral Use in US Adults: 2010-2021

(C-064) Trends in Polycystic Ovary Syndrome and Its Associated Pharmacological Treatments in the United Kingdom from 1998 to 2023

(C-076) Trends in Postpartum Anti-Obesity Medication Use among Commercially Insured Pregnant Women, 2016-2022

(C-102) Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study

(C-104) Trends in Spironolactone Incidence by Indication among Young Women and Girls in the United States: Quantifying Patterns of On-label and Off-label Prescribing

(C-098) Trends in the consumption of psychotropic drugs in France, in children, adolescents and young adults between 2012 and 2023

(C-096) Trends in the Prescription of Central Nervous System Depressants in Patients with Chronic Obstructive Pulmonary Disease in the United Kingdom Primary Care, 2000 – 2022

(C-082) Trends in the Utilization and Persistence on Adjuvant Hormonal Therapy among Women with Invasive Breast Cancer in the United Kingdom, 2004 to 2023.

(C-106) Trends in Utilization, Spending, and Pricing of Janus Kinase (JAK) Inhibitors in the U.S. Medicaid Program (2011-2023)

(B-131) Trends, Patterns, and Characteristics of Gabapentin Use among Medicare Beneficiaries (2012-2021)

(B-123) Use of Glucagon-like Peptide 1 Agonists (GLP-1's) Among Individuals Undergoing Bariatric Surgery In The United States: A Retrospective Cohort Study

(C-077) Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System

(C-083) Use of Statins for Primary Prevention among Individuals with Chronic Kidney Disease in The United States: A Cross-Sectional, Time-Trend Analysis

(B-138) Utilization of VMAT2 Inhibitors for Tardive Dyskinesia Among Adult Antipsychotic Users

(B-136) Utilization Trends of Methadone and Buprenorphine for Opioid Use Disorder in the US Medicaid population

(B-115) Variations in antibiotic use in late premature and term newborns in neonatal care in Sweden 2012-2020

(B-121) Yearly Prevalence of Polycystic Ovary Syndrome (PCOS) Diagnosis in the United States and the Uptake of Management Treatment Following Diagnosis in Commercially Insured Women Aged 18-44